Answers are grounded in this paper and cite their sources.
This enantioselective method improves hydroalkylation in bicyclic compounds, suggesting new pathways for drug synthesis.
Bridged bicyclic structures, exemplified by rigid oxa- and azabicyclic alkanes, are pivotal scaffolds in drug design and natural product synthesis due to their three-dimensional architecture and inherent ring strain. Functionalization of readily available bicyclic alkenes provides a potential pathway to synthesizing molecules with complex cyclic structures. However, strained bicyclic alkenes exhibit thermodynamic reactivity driven by strain energy release, which predominantly favors ring-opening pathways. In contrast, ring-retentive hydroalkylation─a direct method for synthesizing complex bridged bicyclic architectures─remains underdeveloped. Here, we present a cobalt-catalyzed enantioselective hydroalkylation strategy for bicyclo[2.2.1]alkenes that enables ring-retentive addition while constructing tertiary carbon stereocenters within oxa- or azabicyclic frameworks. Mechanistic investigations revealed that the hydrometalation of alkenes serves as the selectivity-determining step, where noncovalent interactions between the catalyst and substrate govern stereoisomeric differentiation. The protocol demonstrates broad compatibility with diverse alkyl iodides and bicyclo[2.2.1]alkenes, facilitating late-stage functionalization of bioactive molecules and enabling the efficient synthesis of antifungal agents with potent activity.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: